Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 15, 2007

View Archived Issues

KRAS mutation predicts response to panitumumab in colorectal cancer

Polyunsaturated fatty acid erythrocyte content, biomarker of colorectal cancer risk

Paliperidone ER improves sleep in patients with schizophrenia

AEGR-733 lowers LDL-cholesterol, body weight in hypercholesterolemic patients

Pooled DUET results show TMC-125 well tolerated in HIV-infected patients

Caspofungin effective in pediatric patients with fungal infections

Reduced levels of the mGlu3 receptor in the prefrontal cortex of schizophrenic patients

Anesiva reports on clinical plans for Adlea

Pharmion and MethylGene evaluate MGCD-0103 and Taxotere combination for solid tumors

C-Path and Ventana collaborate on targeted therapy initiative with FDA and NCI

Recent patents describe new antidiabetic agents

Positive phase II results reported for dry eye treatment ALTY-0501

Proteolix initiates carfilzomib study in relapsed solid tumors patients

Salvat completes enrollment in phase II SVT-40776 trial

NIH to sponsor preclinical DT-22669 diabetes study

Amarin initiates cardiovascular development strategy

Ark spins out eye-related discoveries to Eyecopharm

Drinkable typhoid vaccine candidate achieves phase II endpoints

Enrollment completed in phase I trial of Lenocta

Sontra Medical Corporation changes to Echo Therapeutics

FDA advisory committee recommends approval for Medtronic's drug-eluting stent

European health authorities accept marketing authorization application for alitretinoin

Novel treatment options for obesity and other metabolic disorders described in recent patents

Novel therapeutic agents for infectious diseases disclosed in recent patent literature

A farnesoid X receptor agonist for the treatment of dyslipidemia

FDA approves Isentress tablets for combination treatment of HIV-1

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...